United Health Products (UEEC) Liabilities and Shareholders Equity (2010 - 2026)
United Health Products (UEEC) reported Liabilities and Shareholders Equity of $248825.0 for Q1 2026, up 138.01% year-over-year from $104542.0 in Q1 2025, and down 21.43% quarter-over-quarter from $316698.0 in Q4 2025.
United Health Products (UEEC) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
United Health Products (UEEC) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $248825.0 in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $248825.0, up 138.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $741374.0 (up 14.62% YoY), and the FY2025 annual result was $316698.0, up 17.3% from the prior year.
- Liabilities and Shareholders Equity declined to $248825.0 in Q1 2026 per UEEC's latest filing, from $316698.0 in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $451911.0 in Q3 2022 and troughed at $59097.0 in Q2 2022.
- A 5-year average of $230506.7 and a median of $248825.0 in 2026 frame the typical range for Liabilities and Shareholders Equity.
- On a YoY basis, Liabilities and Shareholders Equity climbed as much as 1207.99% in 2022 and fell as far as 80.47% in 2022.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $350528.0 in 2022, then declined by 18.8% to $284643.0 in 2023, then retreated by 5.15% to $269979.0 in 2024, then grew by 17.3% to $316698.0 in 2025, then dropped by 21.43% to $248825.0 in 2026.
- Business Quant data shows UEEC's Liabilities and Shareholders Equity at $248825.0 in Q1 2026, $316698.0 in Q4 2025, and $94313.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | United Health Products | - | - | - | 248,825.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 248,825.00 |
| Dec 31, 2025 | 316,698.00 |
| Sep 30, 2025 | 94,313.00 |
| Jun 30, 2025 | 81,538.00 |
| Mar 31, 2025 | 104,542.00 |
| Dec 31, 2024 | 269,979.00 |
| Sep 30, 2024 | 150,629.00 |
| Jun 30, 2024 | 121,688.00 |
| Mar 31, 2024 | 233,320.00 |
| Dec 31, 2023 | 284,643.00 |
| Sep 30, 2023 | 335,660.00 |
| Jun 30, 2023 | 433,893.00 |
| Mar 31, 2023 | 303,907.00 |
| Dec 31, 2022 | 350,528.00 |
| Sep 30, 2022 | 451,911.00 |
| Jun 30, 2022 | 59,097.00 |
| Mar 31, 2022 | 77,443.00 |
| Dec 31, 2021 | 26,799.00 |
| Sep 30, 2021 | 329,446.00 |
| Jun 30, 2021 | 193,531.00 |